Literature DB >> 15149321

Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists.

Ravinder S Chana1, Andrew J Lewington, Nigel J Brunskill.   

Abstract

UNLABELLED: Background. Peroxisome proliferator activated receptors (PPARs) are ligand-activated transcription factors with multiple effects on target cell function. PPAR gamma activity is regulated by extracellular signal-regulated protein kinase (ERK), mitogen-activated protein (MAP) kinase, and PPAR gamma ligands have varying effects on activity of ERK. Different PPAR gamma ligands have been shown to have both protective and detrimental effects in the kidney. Since transcriptional activation by different PPAR agonists is ligand- and depot-specific PPAR gamma, we have examined the effects of different agonists on PPAR activity in the proximal tubule.
METHODS: Opossum kidney cells were used in all experiments, transiently transfected with a PPAR response element luciferase reporter and subject to stimulation with various PPAR ligands. The role of ERK and phosphorylation in PPAR gamma activation were studied, as were the effects of PPAR agonists on ERK activation and cell proliferation.
RESULTS: Transcriptional activity of PPAR was not stimulated by PPAR alpha agonists, and only very modestly stimulated by a PPAR beta agonist. The PPAR gamma agonists 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)), ciglitazone, and troglitazone stimulated significant transcriptional activation and phosphorylation of PPAR gamma. These effects were more marked with 15d-PGJ(2). Thiazolidinediones attenuated 15d-PGJ(2) evoked PPAR gamma activation and phosphorylation. ERK activity positively regulated PPAR activation. Only 15d-PGJ(2) stimulated ERK activity and cell proliferation, and these effects were also inhibited by thiazolidinediones.
CONCLUSION: PPAR gamma agonists exert differential effects in proximal tubule cells with thiazolidinediones behaving as partial agonists.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149321     DOI: 10.1111/j.1523-1755.2004.00624.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  11 in total

Review 1.  Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.

Authors:  Emaad M Abdel-Rahman; Lawand Saadulla; W Brian Reeves; Alaa S Awad
Journal:  J Gen Intern Med       Date:  2011-10-18       Impact factor: 5.128

2.  Enterococcus faecalis from newborn babies regulate endogenous PPARgamma activity and IL-10 levels in colonic epithelial cells.

Authors:  Alexandra Are; Linda Aronsson; Shugui Wang; Gediminas Greicius; Yuan Kun Lee; Jan-Ake Gustafsson; Sven Pettersson; Velmurugesan Arulampalam
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-30       Impact factor: 11.205

3.  hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.

Authors:  Yingjian Li; Xiaoyan Wen; Bradley C Spataro; Kebin Hu; Chunsun Dai; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2005-11-16       Impact factor: 10.121

4.  Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions.

Authors:  Anca Nenicu; Yuan Gu; Christina Körbel; Michael D Menger; Matthias W Laschke
Journal:  Br J Pharmacol       Date:  2017-07-06       Impact factor: 8.739

5.  15-deoxy-(Delta12,14)-prostaglandin J2 (15d-PGJ2) induces cell death through caspase-independent mechanism in A172 human glioma cells.

Authors:  W H Cho; C H Choi; J Y Park; S K Kang; Y K Kim
Journal:  Neurochem Res       Date:  2006-10       Impact factor: 3.996

6.  Effect of sitagliptin on proteinuria in patients with type 2 diabetes - A renoprotective effect of sitagliptin.

Authors:  Rouhollah Narimani; Ali Kachuei; Hassan Rezvanian; Awat Feizi; Mohadese Poorpoone
Journal:  J Res Med Sci       Date:  2021-06-30       Impact factor: 1.852

7.  PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis.

Authors:  Jami E Milam; Venkateshwar G Keshamouni; Sem H Phan; Biao Hu; Srinivasa R Gangireddy; Cory M Hogaboam; Theodore J Standiford; Victor J Thannickal; Raju C Reddy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-12-27       Impact factor: 5.464

8.  α1-Antitrypsin Combines with Plasma Fatty Acids and Induces Angiopoietin-like Protein 4 Expression.

Authors:  Eileen Frenzel; Sabine Wrenger; Britta Brügger; Sandeep Salipalli; Stephan Immenschuh; Nupur Aggarwal; Ralf Lichtinghagen; Ravi Mahadeva; A Mario Q Marcondes; Charles A Dinarello; Tobias Welte; Sabina Janciauskiene
Journal:  J Immunol       Date:  2015-09-11       Impact factor: 5.422

9.  Biotransformation of polyunsaturated fatty acids to bioactive hepoxilins and trioxilins by microbial enzymes.

Authors:  Jung-Ung An; Yong-Seok Song; Kyoung-Rok Kim; Yoon-Joo Ko; Do-Young Yoon; Deok-Kun Oh
Journal:  Nat Commun       Date:  2018-01-09       Impact factor: 14.919

10.  Proinsulin C-Peptide Enhances Cell Survival and Protects against Simvastatin-Induced Myotoxicity in L6 Rat Myoblasts.

Authors:  Sumia Mohamed Essid; Alan Bevington; Nigel J Brunskill
Journal:  Int J Mol Sci       Date:  2019-04-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.